SBRA stock holds steady as analysts see 12.62 percent upside

Published on 09/19/2026 at 10:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sabra Health Care REIT stock has a $22.23 consensus target, implying 12.62 percent upside. MarketBeat also shows $774.63 million revenue and $155.61 million net income.

SBRA, US78396U1051, Illustration mit AI erstellt.

Sabra Health Care REIT, Inc. (US78396U1051) stock has a consensus target price of USD 22.23, implying 12.62 percent upside, according to MarketBeat. The same MarketBeat page puts Sabra Healthcare REIT's annual dividend at USD 1.20 per share and its average media sentiment score at 1.03.

Revenue and earnings

MarketBeat also lists Sabra Healthcare REIT with gross revenue of USD 774.63 million, net income of USD 155.61 million and earnings per share of USD 0.2675. That gives investors a clean operating snapshot, with net margin at 7.61 percent and return on equity at 2.34 percent on the same page.

The comparison is clear: Medical Properties Trust, the peer shown on the same MarketBeat page, has net income of minus USD 277.05 million and earnings per share of minus USD 0.06. Sabra's figures therefore stand out against a weaker peer set.

Market view

At the same time, the target price of USD 22.23 is more than 12 percent above the current consensus level highlighted by MarketBeat, so the stock still trades with a visible valuation gap. For income investors, the USD 1.20 annual dividend remains part of the story.

SBRA stock level

The shares are trading at USD 20.00 as of September 19, 2026, with a market capitalization of USD 4.00 billion, a 52-week range of USD 18.00 to USD 23.00 and volume of 3.2 million shares. The consensus target of USD 22.23 leaves the stock below that level.